Sort   by:  
 Page size 
ProteomicsCharacterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses
Introduction: Ampullary cancer is a relatively rare entity and usually treated by pancreatoduodenectomy followed by adjuvant therapy. The intestinal subtype is associated with markedly improved prognosis after resection. Only few cell lines are available for in vitro studies of ampullary cancer and ...
ORGANISM(S): Homo sapiens (Human) 
2016-03-14 | PXD002657 | Pride
Ampullary adenocarcinoma Cell invasion Differentiation Pancreatobiliary Cell proliferation Fibroblast Dysplastic Intestinal 
ClinicalThe ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
Ampullary adenocarcinoma (AAC) is a rare gastrointestinal cancer with varying survival rates, particularly the aggressive pancreatobiliary (PB) subtype. Adjuvant therapy benefits only PB and mixed subtype patients, while prospective studies are required for validation. A study proposes tailored adju...
108044 | ecrin-mdr-crc
UnknownIncreased expression of secreted frizzled related protein 1 (SFRP1) predicts ampullary adenocarcinoma recurrence.
Not available
S-EPMC7413269 | biostudies-literature
ProteomicsProfiling of Kallikrein Proteases and Global Proteome Biology of PDAC, Chronic Pancreatitis and Normal Pancreas
Cell conditioned medium from human pancreatic cancer cell lines MiaPaCa-2, AsPC-1, primary pancreatic cell lines as well as human FFPE tissue samples from pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP), ampullary cancer, non-malignant adjacent pancreas and normal pancreas were an...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000090255 | MassIVE
UnknownGenome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care.
Not available
S-EPMC8563403 | biostudies-literature
UnknownDurable response for ampullary and duodenal adenocarcinoma with a nab-paclitaxel plus gemcitabine ± cisplatin combination.
Not available
S-EPMC6601707 | biostudies-literature
UnknownThe different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
Not available
S-EPMC5522249 | biostudies-literature
UnknownValidation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
Not available
S-EPMC4647538 | biostudies-literature
UnknownNab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation.
Not available
S-EPMC10452745 | biostudies-literature
UnknownSurvival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis.
Not available
S-EPMC8275534 | biostudies-literature
Sort   by:  
 Page size